Lymphoedema and Angiosarcoma (Stewart-Treves Syndrome)

What Is Stewart-Treves Syndrome?

Stewart-Treves syndrome is the name given to an angiosarcoma — a cancer arising from the cells that line blood and lymphatic vessels — that develops in a limb affected by long-standing chronic lymphoedema. It was first described in 1948 in women who developed this tumour in the swollen arm years after a radical mastectomy. Because the cancer grows in the lymph-vessel-rich, fluid-laden tissue of the lymphoedematous limb, it is sometimes also called lymphangiosarcoma.

It is important to keep this in proportion. Stewart-Treves syndrome is rare — only a very small fraction of people with chronic lymphoedema will ever develop it. The vast majority of skin changes, infections (cellulitis) and colour variations seen on a swollen limb are not cancer. But the syndrome is real, it is aggressive, and it is far more treatable when caught early — which is exactly why every survivor living with lymphoedema benefits from knowing what to watch for. If you want the broader clinical picture of this tumour type, our dedicated angiosarcoma page covers its full range, and you can see how all of this fits together on the sarcoma — overview hub.

Why Can Long-Standing Lymphoedema Lead to Angiosarcoma?

The honest answer is that the exact mechanism is not fully settled, but the link is well established. In a limb with chronic lymphoedema, lymph fluid stagnates in the tissues for years. Several factors in that environment are thought to combine:

• Impaired local immune surveillance. Lymph that cannot drain properly means immune cells do not patrol the tissue normally, so abnormal cells are less likely to be cleared.
• Chronic stimulation of vessel-lining cells. Long-term swelling and the body's attempts to form new lymphatic channels keep the endothelial (vessel-lining) cells in a constant state of growth, which over many years raises the chance of a malignant change.
• Prior radiotherapy. Many survivors with arm lymphoedema have also had radiotherapy to the chest wall or armpit for breast cancer. Radiation is itself an independent risk factor for angiosarcoma in the treated field.

The classic setting is the arm after breast-cancer treatment — particularly after an axillary lymph-node dissection with or without radiotherapy. But the same process can occur in a leg with long-standing lymphoedema from any cause, including filarial lymphoedema, which remains relevant in parts of India. The common thread is years of chronic, unresolved swelling rather than the original cause of the lymphoedema itself. Keeping lymphoedema well controlled is part of long-term care, and our guide to managing lymphoedema after sarcoma treatment covers the day-to-day side of that.

Warning Signs: When a Skin Change on a Swollen Limb Needs Checking

The earliest sign of angiosarcoma after lymphoedema is usually a change in the skin of the swollen limb, not a deep lump. Classically it begins as one or more bruise-like marks that look like a bruise that never appeared from an injury and never fades. Over weeks they may darken, thicken into nodules, multiply, bleed, or break down into a non-healing ulcer. The signs that should prompt a specialist review are:

• A reddish-purple, blue or black bruise-like patch on the swollen limb that you cannot explain by an injury and that does not fade.
• A new raised nodule, lump or thickened plaque growing within the lymphoedematous skin.
• Skin that bleeds easily, weeps, or forms an ulcer that will not heal with normal dressings.
• Discolouration that is visibly spreading or changing over weeks rather than staying stable.

How Lymphoedema-Associated Angiosarcoma Is Diagnosed

Because the warning signs overlap with harmless skin changes, infections and the ordinary appearance of lymphoedema, the diagnosis cannot be made by looking alone. A clear, stepwise workup is what separates a confident answer from guesswork.

Step 1 — Specialist Skin Examination

A sarcoma specialist examines the whole limb, notes the size, colour, number and pattern of any lesions, and distinguishes likely infection from a possible tumour. Old photographs are genuinely useful here — they show whether a patch is new or has been changing, which is one of the most important clues.

Step 2 — Skin Biopsy (the Decisive Test)

A punch or incisional skin biopsy of the suspicious area is the test that confirms or rules out angiosarcoma. The tissue is examined under the microscope and stained with vascular markers (immunohistochemistry such as CD31, CD34 and ERG) that identify the cancer as arising from vessel-lining cells. No scan can replace this step — a biopsy is the only way to be certain, and it is a quick procedure done under local anaesthetic.

Step 3 — Staging Imaging

If angiosarcoma is confirmed, an MRI of the limb maps how far the disease extends through the skin and soft tissue, and a CT scan of the chest checks the lungs — the most common site for angiosarcoma to spread. This staging tells the team whether the disease is confined to the limb or has travelled, which shapes the whole treatment plan.

Step 4 — Multidisciplinary Tumour Board

The biopsy result and imaging are brought to a tumour board where a surgical oncologist, medical oncologist, radiation oncologist and pathologist agree the plan together. Angiosarcoma is uncommon and aggressive enough that it should never be managed by a single doctor working alone — joint planning is the standard of care, and it is how every sarcoma case is handled at CION.

How It Is Treated

Treatment is tailored to how far the disease has spread, the patient's general health, and the condition of the limb. The three main pillars are often combined:

Because Stewart-Treves syndrome is aggressive and can recur, close follow-up after treatment is essential — regular skin checks of the limb and periodic chest imaging to catch any return early. The single most powerful factor in outcome remains how early the diagnosis is made, which loops back to the most important message on this page: a persistent, changing skin patch on a long-swollen limb deserves a prompt look. You can read about the surgical and systemic options for sarcoma more broadly on our sarcoma treatment in Hyderabad page.

Outlook, and What Survivors Can Do

Angiosarcoma is an aggressive cancer, and Stewart-Treves syndrome historically carried a guarded outlook because it was often diagnosed late, after years of swelling had masked the early signs. That is exactly why the message of this page is hopeful in a practical way: the outcome is strongly tied to how early the disease is found and treated. A bruise-like patch caught and biopsied within weeks is a very different situation from one that has been dismissed for months.

There is no proven way to guarantee prevention, but sensible long-term lymphoedema care matters. Keeping the swelling well controlled with compression and physiotherapy, preventing and promptly treating infections (cellulitis), protecting the skin from injury, and — crucially — knowing the warning signs and acting on them are all within a survivor's control. Our practical guide to managing lymphoedema after sarcoma treatment covers compression and skin care in detail.

Indicative Cost in Hyderabad

Costs are indicative. A personalised estimate is provided after your CION consultation. EMI options and cashless support through major TPAs, Aarogyasri, CGHS, ECHS & ESI are available for eligible patients.

Why Survivors Choose CION for Suspected Stewart-Treves Syndrome

A rare, fast-moving cancer needs a team that recognises it early and treats it decisively. Here is why survivors trust CION.

Get Peace of Mind, or Get Treated Early

Most skin changes on a swollen limb turn out to be harmless — and the few that are not are most treatable when caught early. Either way, a quick specialist review is worth it. Talk to our sarcoma team today.